|
|
|
Volumn , Issue 364, 2001, Pages
|
|
Tenofovir: Gilead applies for approval; expanded access liberalized.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DRUG DERIVATIVE;
ORGANOPHOSPHORUS COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
TENOFOVIR;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
DRUG APPROVAL;
DRUG INDUSTRY;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE DELIVERY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
ORGANIZATION AND MANAGEMENT;
UNITED STATES;
VIRUS LOAD;
ADENINE;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
DRUG APPROVAL;
DRUG INDUSTRY;
HEALTH SERVICES ACCESSIBILITY;
HIV INFECTIONS;
HUMANS;
ORGANOPHOSPHORUS COMPOUNDS;
PHOSPHONIC ACIDS;
REVERSE TRANSCRIPTASE INHIBITORS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VIRAL LOAD;
|
|
EID: 0035844292
PISSN: 10524207
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
